This partnership will create an opportunity for the pharmaceutical industry to develop and manufacture clinical materials and secure industrial scale production under cGMP with Hovione, using Laxxon ...
3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision ...
NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Laxxon Medical, a US-based pharma-technology company pioneering a new generation of advanced oral drug delivery systems, announced today its attendance at ...
The cooperation between Laxxon and Adare enables the clinical and commercial production of advanced drug delivery systems at Adare’s cGMP facilities in Italy and US NEW YORK CITY, NY / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results